TrialCancer immunology, immunotherapy : CII2019

Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials.

Lijun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.